Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis

F. Briggs, Erika S. Trapl, F. Mateen, Alessandro De Nadai, Devon S. Conway, Douglas D. Gunzler
{"title":"Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis","authors":"F. Briggs, Erika S. Trapl, F. Mateen, Alessandro De Nadai, Devon S. Conway, Douglas D. Gunzler","doi":"10.7224/1537-2073.2023-004","DOIUrl":null,"url":null,"abstract":"\n ACTIVITY AVAILABLE ONLINE: To access the article and evaluation online, go to https://www.highmarksce.com/mscare.\n TARGET AUDIENCE: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, social workers, and other health care providers involved in the management of patients with multiple sclerosis (MS).\n LEARNING OBJECTIVE: Describe the extent to which common social and health disparities contribute to racial differences in ambulatory impairment in MS. Recognize the importance of distinguishing mediators from confounders in multivariable regression models.\n ACCREDITATION:\n In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Intellisphere, LLC. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.\n This activity was planned by and for the health care team, and learners will receive .5 Interprofessional Continuing Education (IPCE) credit for learning and change.\n PHYSICIANS: The CMSC designates this journal-based activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\n NURSES: The CMSC designates this enduring material for .5 contact hour of nursing continuing professional development (NCPD) (none in the area of pharmacology).\n PSYCHOLOGISTS: This activity is awarded .5 CE credit.\n SOCIAL WORKERS: As a Jointly Accredited Organization, the CMSC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive .5 general continuing education credits.\n DISCLOSURES: It is the policy of the Consortium of Multiple Sclerosis Centers to mitigate all relevant financial disclosures from planners, faculty, and other persons that can affect the content of this CE activity. For this activity, all relevant disclosures have been mitigated.\n Francois Bethoux, MD, editor in chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed no relevant financial relationships. Alissa Mary Willis, MD, associate editor of IJMSC, has disclosed not relevant financial relationships. Authors Farren B.S. Briggs, PhD, ScM; Farrah J. Mateen, MD, PhD; Devon Conway, MD, MS; Alessandro de Nadai, PhD; Erika S. Trapl, PhD; and Douglas D. Gunzler, PhD, have disclosed no relevant financial relationships.\n The staff at IJMSC, CMSC, and Intellisphere, LLC who are in a position to influence content have disclosed no relevant financial relationships. Laurie Scudder, DNP, NP, continuing education director CMSC, has served as a planner and reviewer for this activity. She has disclosed no relevant financial relationships.\n METHOD OF PARTICIPATION:\n Release Date: January 1, 2024; Valid for Credit through: January 1, 2025\n To receive CE credit, participants must: (1) Review the continuing education information, including learning objectives and author disclosures.(2) Study the educational content.(3) Complete the evaluation, which is available at https://www.highmarksce.com/mscare.\n Statements of Credit are awarded upon successful completion of the evaluation. There is no fee to participate in this activity.\n DISCLOSURE OF UNLABELED USE: This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. The CMSC and Intellisphere, LLC do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the CMSC or Intellisphere, LLC.\n DISCLAIMER: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.","PeriodicalId":502512,"journal":{"name":"International Journal of MS Care","volume":"19 20","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of MS Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7224/1537-2073.2023-004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

ACTIVITY AVAILABLE ONLINE: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. TARGET AUDIENCE: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, social workers, and other health care providers involved in the management of patients with multiple sclerosis (MS). LEARNING OBJECTIVE: Describe the extent to which common social and health disparities contribute to racial differences in ambulatory impairment in MS. Recognize the importance of distinguishing mediators from confounders in multivariable regression models. ACCREDITATION: In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Intellisphere, LLC. The CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the health care team, and learners will receive .5 Interprofessional Continuing Education (IPCE) credit for learning and change. PHYSICIANS: The CMSC designates this journal-based activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. NURSES: The CMSC designates this enduring material for .5 contact hour of nursing continuing professional development (NCPD) (none in the area of pharmacology). PSYCHOLOGISTS: This activity is awarded .5 CE credit. SOCIAL WORKERS: As a Jointly Accredited Organization, the CMSC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive .5 general continuing education credits. DISCLOSURES: It is the policy of the Consortium of Multiple Sclerosis Centers to mitigate all relevant financial disclosures from planners, faculty, and other persons that can affect the content of this CE activity. For this activity, all relevant disclosures have been mitigated. Francois Bethoux, MD, editor in chief of the International Journal of MS Care (IJMSC), has served as physician planner for this activity. He has disclosed no relevant financial relationships. Alissa Mary Willis, MD, associate editor of IJMSC, has disclosed not relevant financial relationships. Authors Farren B.S. Briggs, PhD, ScM; Farrah J. Mateen, MD, PhD; Devon Conway, MD, MS; Alessandro de Nadai, PhD; Erika S. Trapl, PhD; and Douglas D. Gunzler, PhD, have disclosed no relevant financial relationships. The staff at IJMSC, CMSC, and Intellisphere, LLC who are in a position to influence content have disclosed no relevant financial relationships. Laurie Scudder, DNP, NP, continuing education director CMSC, has served as a planner and reviewer for this activity. She has disclosed no relevant financial relationships. METHOD OF PARTICIPATION: Release Date: January 1, 2024; Valid for Credit through: January 1, 2025 To receive CE credit, participants must: (1) Review the continuing education information, including learning objectives and author disclosures.(2) Study the educational content.(3) Complete the evaluation, which is available at https://www.highmarksce.com/mscare. Statements of Credit are awarded upon successful completion of the evaluation. There is no fee to participate in this activity. DISCLOSURE OF UNLABELED USE: This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. The CMSC and Intellisphere, LLC do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the CMSC or Intellisphere, LLC. DISCLAIMER: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
共同的社会和健康差异导致多发性硬化症患者行动障碍的种族差异
在线活动:要在线访问文章和评估,请访问 https://www.highmarksce.com/mscare。目标受众:本活动的目标受众是参与多发性硬化症(MS)患者管理的医生、高级临床医师、护理专业人员、社会工作者和其他医疗服务提供者。学习目标:描述常见的社会和健康差异在何种程度上导致了多发性硬化症行动障碍的种族差异。认识在多变量回归模型中区分中介因素和混杂因素的重要性。认证:为支持改善患者护理,多发性硬化症中心联盟(CMSC)和 Intellisphere, LLC 计划并实施了这项活动。多发性硬化症中心联盟由继续医学教育认证委员会 (ACCME)、药学教育认证委员会 (ACPE) 和美国护士资格认证中心 (ANCC) 联合认证,为医疗团队提供继续教育。该活动由医疗团队策划并为医疗团队服务,学习者将获得 0.5 个跨专业继续教育 (IPCE) 学分,用于学习和改变。医生:CMSC 指定本期刊活动最多可获得 0.5 个 AMA PRA 1 类学分™。医生只能申请与其参与活动程度相称的学分。护士:CMSC 指定本持久材料可获得 0.5 个护理继续职业发展 (NCPD) 接触小时(无药理学领域)。心理学家:本活动可获得 0.5 CE 学分。社会工作者:作为联合认证组织,CMSC 经社会工作委员会协会(Association of Social Work Boards, ASWB)批准,可提供社会工作继续教育(Approved Continuing Education, ACE)项目。该计划批准的是组织,而非个别课程。监管委员会是接受继续教育学分课程的最终权威机构。完成此课程的社会工作者可获得 0.5 个普通继续教育学分。披露:多发性硬化症中心联盟的政策是减少策划者、教师和其他可能影响本继续教育活动内容的人员披露的所有相关财务信息。对于本次活动,所有相关披露均已减少。国际多发性硬化症护理杂志》(International Journal of MS Care, IJMSC)主编、医学博士 Francois Bethoux 担任本次活动的医生策划人。他未披露任何相关财务关系。艾丽莎-玛丽-威利斯(Alissa Mary Willis)医学博士是《国际多发性硬化症护理杂志》(IJMSC)的副主编,她未披露任何相关财务关系。作者 Farren B.S. Briggs(医学博士)、Farrah J. Mateen(医学博士)、Devon Conway(医学博士)、Alessandro de Nadai(医学博士)、Erika S. Trapl(医学博士)和 Douglas D. Gunzler(医学博士)未披露任何相关财务关系。IJMSC、CMSC 和 Intellisphere, LLC 公司中能够影响内容的员工均未披露任何相关财务关系。CMSC 继续教育主任、DNP、NP 劳里-斯卡德(Laurie Scudder)是本次活动的策划者和审核者。她未披露任何相关财务关系。参与方式:发布日期:发布日期:2024 年 1 月 1 日;学分有效期:2025 年 1 月 1 日:为获得 CE 学分,参与者必须(1)查看继续教育信息,包括学习目标和作者披露。(2)学习教育内容。(3)完成评估,评估结果可从 https://www.highmarksce.com/mscare 网站获取。成功完成评估后可获得学分证明。参加本活动不收取任何费用。披露无标签使用:本教育活动可能包含对未经 FDA 批准的药剂的已公布和/或研究用途的讨论。CMSC 和 Intellisphere, LLC 不建议在标示适应症之外使用任何药物。教育活动中表达的观点仅代表教员的意见,并不一定代表 CMSC 或 Intellisphere, LLC 的观点。免责声明:参与者有责任使用新获得的信息来提高患者的治疗效果和自身的专业发展。本活动中提供的信息无意作为患者管理的指南。临床医生或其他医疗保健专业人员在使用本出版物中讨论的任何药物、诊断程序或治疗方法时,应首先评估患者的病情,考虑可能的禁忌症或风险,查看任何适用的制造商产品信息,并将任何治疗方法与其他权威机构的建议进行比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Validity and Reliability of the Turkish Version of the Patient-Reported Impact of Spasticity Measure in Multiple Sclerosis Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Cognitive Performance in Adults With Multiple Sclerosis The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multi-Methods Study Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis Abstracts from the 34th Annual Meeting of the Consortium of Multiple Sclerosis Centers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1